Selenium intakes may be "suboptimal" for prostate cancer risk reduction -- Harvard study.
SELENIUM RECOMMENDED INTAKE MAY BE "SUBOPTIMAL" FOR PROSTATE CANCER risk reduction, Kazuko Yoshizawa, Harvard School of Public Health, et al., state in a study in the Aug. 19 Journal of the National Cancer Institute. The researchers report a "strong inverse association between the prediagnostic selenium level assessed" in study participants and the risk of advanced prostate cancer. Higher selenium intake levels among participants, as measured in toenail clippings collected by the researchers, were found to be associated with a lower risk of advanced prostate cancer.
More from Archive
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
A new pilot aims to take Brazil closer to ‘digital transformation.’
More from Pink Sheet
The whole contract research organization industry is being impacted by the current volatility in the pharmaceutical industry.
The 14 July deadline for the Citeline Japan Awards 2025 in Tokyo is approaching fast, so here's a reminder to take a look at the categories and criteria and be sure to get your submissions in by this date. Sponsorship opportunities and tables for the event are also available.
HHS Secretary Kennedy's new ACIP appointments include multiple members of anti-vaccine groups and people who have spread misinformation about COVID-19 vaccines.